TP53 and neoplasm: For instance, the genes ImpL2, an insulin/insulin-like growth factor antagonist recently reported to mediate tumour-induced organ wasting34, 35, and p53, which reprograms tumour metabolism36, were both upregulated in Sox21a EBs (Fig. 5d).